Antiepileptic drugs: Affective use in autism spectrum disorders

Pediatric Neurology

Volumn 25, Issue 3, 2001, Pages 199-207

  Di Martino, Adriana ^a   Tuchman, Roberto F ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; LAMOTRIGINE; NEUROTRANSMITTER; NORADRENALIN; PAROXETINE; SEROTONIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

AFFECTIVE NEUROSIS; ARTICLE; AUTISM; BEHAVIOR; DRUG EFFECT; DRUG EFFICACY; DRUG USE; EPILEPSY; EPILEPTIC DISCHARGE; HUMAN; INCIDENCE; INTERPERSONAL COMMUNICATION; KINDLING; MENTAL DEFICIENCY; MORBIDITY; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SOCIALIZATION;

EID: 0034812853     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(01)00276-4     Document Type: Review

References (120)

1. Autistic and dysphasic children. I: Clinical characteristics
2. The incidence of seizures among children with autistic symptoms
3. Epilepsy in autism and autistic-like conditions. A population-based study
4. Autistic and dysphasic children. II: Epilepsy
5. Comorbid association of autism and schizophrenia
6. Regression in pervasive developmental disorders: Seizures and epileptiform electroencephalogram correlates
7. Selective cognitive impairment during focal and generalized epileptiform EEG activity
8. The effect of focal interictal spikes on perception and reaction time. II. Neuroanatomic specificity
9. The effect of focal interictal spikes on perception and reaction time. I. General considerations
10. Affective disorders in people with autism: A review of published cases
11. Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use
12. Epilepsy presenting as infantile autism? Two case studies
13. Infantile autism and affective disorder
14. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders
15. Acquired aphasia with convulsive disorder: A pervasive developmental disorder variant
16. Autistic regression in relation to limbic pathology and epilepsy: Report of two cases
17. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits
18. Autism: Electroencephalogram abnormalities and clinical improvement with valproic acid
19. Case summary: Benjamin
20. Valproic acid treatment of epilepsy in autistic twins
21. Medication-induced hypomania in Asperger's disorder
22. Psychiatric disorders accompanying epilepsy in children
23. The psychological disorders of epileptic patients
24. Chronic illness, disability, and mental and social well-being: Findings of the Ontario Child Health Study
25. Psychiatric disturbance in the familiesof epileptic children
26. Psychiatric and behavioral problem in epilepsy, hydrocephalus and cerebral pulsy
27. Psychiatric aspects of epileptic children and adolescents
28. Depression, anxiety, and epilepsy
29. Psychiatric symptom patterns of chronic epileptics attending a neurological clinic: A controlled investigation
30. Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy
31. Depression in complex partial seizures. Electroencephalography and cerebral metabolic correlates
32. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital, 1978-1983
33. Difficulties in diagnosing manic disorders among children and adolescents
34. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children
35. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder
36. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy
37. A five to fifteen year follow-up study of infantile psychosis. II. Social and behavioural outcome
38. Observations on compulsive behavior in autism
39. Depression in autistic disorder
40. Asperger's syndrome and recurrent psychosis - A case study
41. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation
42. Case study: Comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder
43. Clinical and genetic relationship between autism-pervasive developmental disorder and Tourette syndrome: A sudy of 19 cases
44. Brief report: Cases for an association between Tourette syndrome, autistic disorder, and schizophrenia-like disorder
45. The prevalence of Gilles de la Tourette's syndrome in children and adolescents with autism
46. A child with severe head banging
47. Introduction: Emerging perspectives on valproate in affective disorders
48. Topiramate: A potent anticonvulsant in the amygdala-kindled rat
49. Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats
50. Neurophysiologic and neurochemical principles of the effect of anticonvulsants
51. Does the engram of kindling model the engram of normal long term memory?
52. Antiepileptic drugs in affective illness. Clinical and theoretical implications
53. Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness
54. Kindling: Separate vs. shared mechanisms in affective disorders and epilepsy
55. Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: The role of serotonergic mechanisms in illness progression
56. Role of serotonin receptor subtypes in the development of amygdaloid kindling in rats
57. Effect of amygdala kindling on the in vivo release of GABA and 5-HT in the dorsal raphe nucleus in freely moving rats
58. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: Involvement of 5-hydroxytryptamine2C receptors
59. The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease
60. Effects of carbamazepine on hippocampal serotonergic system
61. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats
62. Carbamazepine-induced release of serotonin from rat hippocampus in vitro
63. GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats
64. Effect of valproic acid on 5-hydroxytriptamine turnover in mouse brain
65. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate
66. Effect of valproic and acid on serotonin metabolism
67. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain
68. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats
69. A calcium antagonistic effect of the new antiepileptic drug lamotrigine
70. Gabapentin augments whole blood serotonin in healthy young men
71. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin
72. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system
73. Effect of gamma-aminobutyric acid on brain serotonin and catecholamines
74. Plasma GABA in children and adolescents with mood, behavior, and comorbid mood and behavior disorders: A preliminary study
75. Low plasma GABA is a trait-like marker for bipolar illness
76. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: A blood test for manic depressive disease?
77. Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression
78. Plasma GABA predicts acute response to divalproex in mania
79. Update on the mechanism of action of antiepileptic drugs
80. 'In vivo' administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain
81. Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children
82. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat
83. Correlation between alterations in brain GABA metabolism and seizure excitability folllowing administration of GABA aminitransferase inhibitors and valproic acid - A reevaluation
84. Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism
85. Mechanisms of action of anticonvulsant agents
86. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs
87. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy
88. Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons
89. Effect of VPA on cerebral aminoacids: Mechanism of GABA elevation and possible casua relation of VPA induced encephalopaty and glutamine level
90. Lamotrigine
91. Interaction of antiepileptic drug lamotrigine with the recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones
92. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA
93. Carbamazepine increases extracellular serotonin concentration: Lack of antagonism by tetrodotoxin or zero Ca2+
94. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: Implications for antiepileptic action and mental function
95. Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: An in vivo microdialysis study
96. Combined lithium and valproate treatment and subsequent withdrawal: Serotonergic mechanism of their interaction in discrete brain regions
97. Lamotrigine: An update of its pharmacology and therapeutic use in epilepsy
98. Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells
99. Valproate and its major metabolite E-2-en-valproate induce different effects on behaviour and brain monoamine metabolism in rats
100. Inhibition of neuronal Ca(2+) by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices
101. Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus
102. Effect of sodium valproate on CSF GABA, cAMP, CGMP and homovanillic acid levels in men
103. Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
104. Inhibition by GABA, baclofen, and gabapentin of dopamine release from rabbit caudate nucleus: Are there common or different sites of action?
105. Effects of fluoxetine treatment in young children with idiopathic autism
106. A family history study of neuropsychiatric disorders in the adult siblings of autistic individuals
107. Autism, affective and other psychiatric disorders: Patterns of familial aggregation
108. Siblings and parents of children with autism: A controlled population-based study
109. Psychiatric disorders in children and adolescents with mental retardation and active epilepsy
110. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism
111. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: Identification of hypoplastic and hyperplastic subgroups with MR imaging
112. The brain in infantile autism: Posterior fossa structures are abnormal
113. Medial temporal lobe structures and autism: A review of clinical and experimental findings
114. Autism: Review of neurochemical investigation
115. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children
116. Abnormalities in brain serotonin concentration, high-affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats
117. Anticonvulsant effect of fluoxetine in humans
118. Lamotrigine therapy for childhood autism: A randomized, double blind, placebo-controlled trial
119. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder